跳至主要内容
临床试验/NCT02782559
NCT02782559撤回2 期

Randomized Double-Blind, Placebo Controlled Evaluation of the Efficacy of Sildenafil Versus Placebo in Preterm Preeclampsia

The University of Texas Health Science Center, Houston0 个研究点开始时间: 2016年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
主要终点
Latency (duration of pregnancy from diagnosis/randomization until delivery)

研究概览

简要总结

Randomized controlled trial to assess efficacy of Sildenafil in addition to expectant management for the treatment of preterm preeclampsia

详细描述

Preeclampsia is a major cause of maternal mortality. When preeclampsia presents prior to thirty-four weeks of gestation, expectant management is the standard practice in stable patients with the goal of extending pregnancy and therefore decreasing the risk of adverse outcomes in the premature neonate. Our aim was to assess the efficacy of Sildenafil, a phosphodiesterase inhibitor, versus placebo, in addition to expectant management, for the treatment of preterm preeclampsia to prolong pregnancy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Hospitalized patients of gestational age of ≥24 0/7 weeks to ≤32 0/7 weeks.
  • Dating of pregnancy by ultrasound < or equal to 22 weeks or IVF conception
  • Diagnosis of Preterm Preeclampsia or Superimposed Preeclampsia

排除标准

  • Need for immediate delivery of the fetus
  • Known lethal anomaly
  • Pre-existing renal disease
  • Hypersensitivity to sildenafil
  • Pre-gestational diabetes, class C (onset prior to 10-19 or duration 10-19 yrs
  • Active peptic ulcer disease
  • Undergoing nitrate therapy

研究组 & 干预措施

Sildenafil

Experimental

Sildenafil 40mg oral tablet three times a day from randomization until delivery

干预措施: Sildenafil (Drug)

Placebo

Placebo Comparator

Matched to oral capsule of active treatment three times a day from randomization until delivery

干预措施: Sildenafil (Drug)

Placebo

Placebo Comparator

Matched to oral capsule of active treatment three times a day from randomization until delivery

干预措施: Placebo (Drug)

结局指标

主要结局

Latency (duration of pregnancy from diagnosis/randomization until delivery)

时间窗: Diagnosis (randomization) until delivery, up to 34 weeks)

earliest randomization can occur at 24 weeks gestation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验